期刊文献+

丙型肝炎患者基线T细胞分化状态与快速病毒学应答的相关性分析 被引量:4

Differentiations of CD8^+ T-cell before Treatment Are Associated with the Rapid Virological Response to Antiviral Therapy in Patients Chronically Infected with Hepatitis C Virus
暂未订购
导出
摘要 目的探讨慢性丙型肝炎患者基线T细胞分化状态与抗病毒治疗快速病毒学应答(RVR)的关系。方法采用流式细胞仪检测CD27和CD28在CD8+T细胞上的表达,根据其表达差异,判断CD8+T细胞的不同分化状态:早期(CD28+/CD27+)、中期(CD28-/CD27+)和晚期(CD28-/CD27-);比较抗病毒治疗获得RVR组和非RVR组的基线CD27、CD28的表达水平及T细胞分化状态的差异。结果获得RVR组的CD27、CD28在CD8+T细胞的表达均高于未获得RVR组,差异有统计学意义(P=0.004,P=0.01)。T细胞的分化状态在RVR组以早、中期为主,而在非RVR组以晚期T细胞分化状态为主,2组之间差异有统计学意义(P<0.01)。结论基线T细胞的分化状态与干扰素联合利巴韦林抗病毒治疗慢性丙型肝炎RVR有一定相关性,可能与机体T细胞免疫在干扰素的免疫调节下参与病毒清除有关。 Objective To investigate the association between the differentiations of CD8+ T cell before treatment and the rapid virological response to antiviral therapy in patients infected with hepatitis C virus(HCV). Methods The presences of CD27 and CD28 on the surface of CD8+ T-cell were monitored using flow cytometry in 40 patients chronically infected with HCV before treatment with pegylated alpha interferon and ribavirin. The differentiations of CD8+T cell were assessed at early stage(CD28+/CD27+),intermediate stage(CD28-/CD27+) and late stage(CD28-/CD27-). Then,a comparison on differentiations of CD8+T cells between patients who presented a rapid virological response(RVR) to therapy and those who did not show any RVR(no RVR) was performed. Results A clear difference in the presences of CD27 and CD28 on the surface of CD8+ T-cell was found:in patients with RVR,the percentages of CD27 and CD28 were much higher than those in patients without RVR,the difference was significant(P=0.004 and P=0.01,respectively). Moreover,the differentiations of CD8+T cells were compared between patients with RVR and without RVR:in patients with RVR,the dominant cells were the ones in early/intermediate stage,while,a late differentiation process of CD8 T cells might be associated with lack of rapid response to treatment. Conclusion The differentiations of CD8+ T cell before treatment are related to the rapid virological response to antiviral therapy in patients infected with HCV,this phenomenon indicates that cytotoxic T cell may be involved in the clearance of HCV during the treatment with interferon.
出处 《首都医科大学学报》 CAS 北大核心 2009年第6期775-779,共5页 Journal of Capital Medical University
基金 国家"十一五"科技重大专项(2008ZX10002-013)资助项目~~
关键词 慢性丙型肝炎 快速病毒学应答 细胞分化 抗病毒治疗 干扰素 基线 利巴韦林 状态 细胞毒性 聚乙二醇化 chronic hepatitis C rapid virological response cell differentiation
  • 相关文献

参考文献17

  • 1Rahnavardi M, Hosseini Moghaddam S M, Alavian S M. Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures[ J]. Am J Nephrol, 2008,28:628-640.
  • 2Krawitt E L, Ashikaga T, Gordon S R, et al. Peginterferon alfa-2b and ribavirin for treatment-refractory chronic hepatitis C [ J]. J Hepatol, 2005,43:243-249.
  • 3Manns M P, McHutchison J G, Gordon S C, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial[J]. Lancet, 2001,358:958-965.
  • 4Kamal S M, Ismail A, Graham C S, et al. Pegylated interferon alpha therapy in acute hepatitis C : relation to hepatitis C virus-specific T cell response kinetics [ J ]. Hepatology, 2004,39 : 1721- 1731.
  • 5丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:733
  • 6Price D A, Klenerman P, Booth B L, et al. Cytotoxic T lymphocytes, chemokines and antiviral immunity [ J ]. Immunol Today, 1999,20:212-216.
  • 7Gruner N H, Gerlach T J, Jung M C, et al. Association of hepatitis C virus-specific CD8 + T cells with viral clearance in acute hepatitis C [ J]. J Infect Dis, 2000, 181 : 1528- 1536.
  • 8Thimme R, Oldach D, Chang K M, et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection[J]. J Exp Med, 2001,194:1395- 1406.
  • 9Rehermann B, Chang K M, McHutchinson J, et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients [ J ]. J Virol, 1996,70:7092- 7102.
  • 10Lechner F, Wong D K, Dunbar P R, et al. Analysis of successful immune responses in persons infected with hepatitis C virus[J]. J Exp Med, 2000,191,1499- 1512.

二级参考文献19

  • 1陆德源.现代免疫学[M].上海:上海科学技术出版社,1998.14-16.
  • 2Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 3Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 4Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 5Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 6Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 7Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
  • 8Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.
  • 9Di Ciomm no V, Russo P, Rava L, etal. Interferon alpha in the treatment of chronic hepatitis C in children: a mmeta- analysis[J] .J Viral Hepat,2003,10:210 - 214.
  • 10Fabrizi F, Dulai G, DixitV, et al. Meta- analysis: interfeorn for the treatment of chronic hepatitis C in dialysis patients[J] .Aliment Phamacol Ther, 2003,18:1071 - 1081.

共引文献732

同被引文献89

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部